Show simple item record

dc.contributor.advisorGomes, Rahul
dc.contributor.authorKeller, Paige
dc.contributor.authorMorehead, Samuel
dc.contributor.authorCaterer, Zachary
dc.date.accessioned2025-04-28T15:40:17Z
dc.date.available2025-04-28T15:40:17Z
dc.date.issued2024-04
dc.identifier.urihttp://digital.library.wisc.edu/1793/95097
dc.descriptionColor poster with text, charts, and graphs.en_US
dc.description.abstractDNA methylation is a process that can affect gene accessibility and therefore gene expression. Methylation can affect genes that are associated with suppressing or contributing to tumor growth and progression. In this research, we examined the potential of developing a scalable feature selection and deep learning framework capable of processing high dimensional genomic datasets to identify methylation sites in the human genome responsible for pancreatic ductal adenocarcinoma (PDAC). The methylation data being analyzed consisted of almost 485,578 CPG markers. Feature selection using Random Forest and Anova was performed along with random undersampling. Selected markers and gene expression data was analyzed to identify enriched pathways. Genes identified in pathways were studied for tumor progression. When compared with a list of 339 genes that were identified from literature, our results returned 98 common tumor genes including “KRAS", "BRCA1", "BRCA2", "PALB2", "CDKN2A", "TP53", "SMAD4". This reveals that the stratified feature selection technique is indeed useful at identifying important features. Finally a deep learning classifier was developed for identifying patients with PDAC. Data for this research was obtained from TCGA-PAAD project. Current work is focused on analyzing gene expression data and combine outcomes with methylation dataset to get deeper insights into the disease mechanisms. PDAC, or pancreatic ductal adenocarcinoma, is the most prevalent kind of pancreatic cancer, making up over 90% of cases. Aggressive tumor growth, early metastasis, and resistance to therapy are characteristics of this highly fatal cancer. Improving diagnosis, prognosis, and treatment outcomes require a thorough understanding of the molecular pathways underlying PDAC development and progression. The proposed research outcomes could aid in the development of non-invasive diagnostic tests and personalized treatment strategies.en_US
dc.description.sponsorshipNational Institute of General Medical Sciences of the National Institutes of Health, under NDSU COBRE Award Number 1P20GM109024; NIH grant P30 CA77598; National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR002494; University of Wisconsin--Eau Claire Office of Research and Sponsored Programsen_US
dc.language.isoen_USen_US
dc.relation.ispartofseriesUSGZE AS589;
dc.subjectMachine learningen_US
dc.subjectDNA Methylationen_US
dc.subjectPancreatic canceren_US
dc.subjectPostersen_US
dc.subjectDepartment of Computer Scienceen_US
dc.titleA Machine Learning Approach Towards Prediction of Pancreatic Cancer Using Gene Expression and DNA Methylationen_US
dc.typePresentationen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • CERCA
    Posters of collaborative student/faculty research presented at CERCA

Show simple item record